+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new cognition-enhancing agent, (R)-(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride. Effects on memory impairment in rats generated by cerebral embolization and basal forebrain lesions



A new cognition-enhancing agent, (R)-(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride. Effects on memory impairment in rats generated by cerebral embolization and basal forebrain lesions



Biological and Pharmaceutical Bulletin 18(12): 1779-1783



The title compound (T-588) has been evaluated for its ameliorating effect on memory impairment generated by cerebral embolization and by a basal forebrain (BF) lesion in male Wistar rats. The memory and learning deficits induced by injection of carbon-microspheres into the internal carotid artery were significantly improved by T-588 at oral dose of 3-10 mg/kg, as determined by an active avoidance response assay, whereas the reference drugs (tacrine, idebenone and indeloxazine) proved almost inactive in the same assay procedure. As far as the embolization was concerned, a significant decrease in cerebral acetylcholine and monoamines was observed. The effect on the memory impairment caused by an electrolytic lesion of the BF was assessed by a passive avoidance task. T-588 exhibited a bell-shaped dose-response curve and was most active at 1 mg/kg (oral dose), while tacrine showed equal activity at 10 mg/kg.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079537

Download citation: RISBibTeXText

PMID: 8787808


Related references

A New Cognition-Enhancing Agent, (R)-(-)-1-(Benzo(b)thiophen-5-yl)-2-(2-(N,N-diethylamino)ethoxy)ethanol Hydrochloride. Effects on Memory Impairment in Rats Generated by Cerebral Embolization and Basal Forebrain Lesions. Biological & Pharmaceutical Bulletin 18(12): 1779-1783, 1995

Protective effect of R(-)-1-(benzo[b]thiophen-5-yl)- 2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia. Japanese Journal of Pharmacology 62(1): 81-86, 1993

Protective Effect of R(-)-1-(Benzo(b)thiophen-5-yl)-2-(2-(N,N-diethylamino)ethoxy)ethanol Hydrochloride (T-588), a Novel Cerebral Activator, aganinst Experimental Cerebral Anoxia. The Japanese Journal of Pharmacology 62(1): 81-86, 1993

Effects of R(-)-1-(benzo[b]thiophen-5-yl)-2-[2-N,N-diethylamino)ethoxy]ethan ol hydrochloride (T-588), a novel cognitive enhancer, on noradrenaline release in rat cerebral cortical slices. Biochemical Pharmacology 53(9): 1263-1269, 1997

Neuroprotective effects of R(-)-1-(benzo[b]thiophen-5-yl)-2- [2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588) against retinal ganglion cell death induced by elevated intraocular pressure in rat. Japanese Journal of Ophthalmology 46(6): 621-626, 2003

Effects of idebenone cv 2619 on memory impairment in rats with the basal forebrain lesions. Journal of Takeda Research Laboratories 44(1-2): 34-41, 1985

Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions. Journal of Pharmacology and Experimental Therapeutics 248(2): 825-835, 1989

Urinary incontinence and memory impairment in rats with basal forebrain lesions and improvement by treatment with a cerebral energy metabolism enhancer associated with recovery of lcgu. Society for Neuroscience Abstracts 17(1-2): 1589, 1991

Recombinant human ngf ameliorate memory impairment in rats with basal forebrain lesions. Society for Neuroscience Abstracts 17(1-2): 223, 1991

Cholinergic system and memory in the rat effects of chronic ethanol embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system. Neuroscience 33(3): 435-462, 1989

The effects of neonatal basal forebrain lesions on cognition: towards understanding the developmental role of the cholinergic basal forebrain. International Journal of Developmental Neuroscience 16(7-8): 603-612, 1999

Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions. Pharmaceutical Research 15(12): 1907-1910, 1999

Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions. Pharmaceutical Research (New York) 15(12): 1907-1910, 1998

Effects of SDZ ENA 713 on spatial memory impairment in basal forebrain-lesioned rats. Japanese Journal of Pharmacology 64(SUPPL 1): 353P, 1994

Effects of the new cognition-enhancing agent nefiracetam in rats with cerebral embolism. Arzneimittel-Forschung 42(11): 1274-1278, 1992